Pabrinex shortage and guidance on alternatives
Pabrinex IV will be out of stock from July/ August 2024 until September 2025, due to supply issues relating to manufacturing regulations issued by the EU. Pabrinex IM will be permanently discontinued from December 2024. Pabrinex is only used in the UK, with thiamine IV/ IM being routinely used globally.
It is important to note if a Patient Group Direction (PGD) is being used (often used in community setting), only licensed products can be used in this setting. Therefore IM Pabrinex should be conserved for this purpose.
The following has been published online by the DHSC Specialist Pharmacy Service.
Joanna Henry, Gastroenterology Directorate Pharmacist, Liverpool University Hospitals NHS Trust
Sital Shah, Chair British Hepatology Pharmacy Group , Consultant Pharmacist, King’s College Hospital, London
Applications are open for the role of BSG Deputy Vice President Endoscopy
Applications are now open for the role of BSG Deputy Vice President Endoscopy from June 2026 until June 2028. Applications accepted until Thursday 2nd April 2026.
Applications are open for the role of BSG Deputy Chair Research
Applications are now open for the role of BSG Deputy Chair Research from June 2026. Applications accepted until Thursday 26th March 2026.
Applications open for the BSG Clinical Services committee Chair and the BSG Deputy Chair/QI Lead
Applications are now open for the roles of the BSG Clinical Services committee Chair and the BSG Deputy Chair/QI Lead.